ALLOIMMUNE-MEDIATED APOPTOSIS
- 1 March 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (6) , 904-909
- https://doi.org/10.1097/00007890-199903270-00019
Abstract
The purpose of the present study was (1) to compare apoptotic activity in models of acute and chronic rejection and (2) to study the cellular distribution of parenchymal versus inflammatory cell apoptosis. Heterotopic cardiac mouse transplantation (CBA into C57BL/6) was used to produce allografts undergoing acute (day 7, untreated recipients, n=6) or chronic (day 55, anti-CD4/8 for 28 days, n=6) rejection. As references, we used 55-day isograft controls (n=5) and native hearts (n=6). To assess apoptotic activity, we quantified DNA laddering (32P incorporation), DNA fragmentation (antinucleosome ELISA), and caspase-1 transcript levels (32P-reverse transcriptase-polymerase chain reaction). To localize apoptosis, we performed terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling. DNA laddering and nucleosome levels were increased in allografts undergoing acute or chronic rejection when compared with both controls. Both parameters were twofold higher in acutely compared with chronically rejecting hearts. Caspase-1 transcript levels were increased in acutely (P<0.0001) and chronically rejecting hearts (P=0.004). Acutely rejecting grafts had more terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive nuclei (53+/-3 nuclei/high-powered field) than chronically rejecting grafts (9+/-1 nuclei/high-powered field, P<0.0001), but the distribution between graft-infiltrating inflammatory cells and myocytes was similar. Vascular cells undergoing apoptosis were infrequent in both forms. Using four separate indices, apoptotic activity is more pronounced in cardiac allografts undergoing acute compared with chronic rejection. This reflects, in part, the degree of alloimmune response. However, we speculate that the contributions of apoptosis to various forms of rejection are multifactorial. The long-term outcome to the graft may depend upon the magnitude, timing, and target of programmed cell death.Keywords
This publication has 18 references indexed in Scilit:
- The use of technetium tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejectionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Cyclosporin A Inhibits Apoptosis of Human Endothelial Cells by Preventing Release of Cytochrome C From MitochondriaCirculation, 1998
- PROGRAMMED CELL DEATHTransplantation, 1998
- Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis.Journal of Clinical Investigation, 1998
- Apoptosis Is Involved in Acute Cardiac Allograft Rejection in RatsThe Annals of Thoracic Surgery, 1998
- In vivo detection and imaging of phosphatidylserine expression during programmed cell deathProceedings of the National Academy of Sciences, 1998
- APOPTOSIS AND INCREASED EXPRESSION OF INDUCIBLE NITRIC OXIDE SYNTHASE IN HUMAN ALLOGRAFT REJECTION1Transplantation, 1998
- Sustained Anti-CD4/CD8 Treatment Blocks Inflammatory Activation and Intimal Thickening in Mouse Heart AllograftsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- APOPTOSIS IN MURINE CARDIAC GRAFTS1,2,3Transplantation, 1997
- Apoptosis of Cardiac Myocytes During Cardiac Allograft RejectionCirculation, 1996